2026 Global: Medical Engineered Materials Market-Competitive Review (2032) report
Description
The 2026 Global: Medical Engineered Materials Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The medical engineered materials market features major players specializing in advanced polymers, plastics, foams, and adhesives for devices like implants, diagnostics, and surgical tools. Leading companies include B. Braun Melsungen AG (headquartered in Melsungen, Germany), BASF SE (Ludwigshafen, Germany), Celanese Corporation (Irving, Texas, USA), Covestro AG (Leverkusen, Germany), DSM (Heerlen, Netherlands), DuPont de Nemours Inc. (Wilmington, Delaware, USA), Eastman Chemical Company (Kingsport, Tennessee, USA), Evonik Industries AG (Essen, Germany), Huntsman Corporation (The Woodlands, Texas, USA), and Johnson & Johnson (New Brunswick, New Jersey, USA). These firms drive innovation through biocompatible materials, sustainability-focused polymers, and high-performance composites, supporting a market projected to grow from USD 23.9 billion in 2024 to USD 82.9 billion by 2033 at a 14.8% CAGR. B. Braun excels in infusion therapy components using engineered plastics, while BASF provides specialty chemicals for medical coatings and foams.
Evonik Industries AG leads with specialty polymers for implants and additive manufacturing, emphasizing biocompatibility and circular economy practices via collaborations with OEMs. Covestro AG develops polyurethane-based medical foams and films for wound care and flexible devices, bolstered by its chemical expertise. DSM, now Royal DSM N.V., pioneers bio-based polymers for orthopedics and cardiovascular applications, prioritizing patient-specific durability. DuPont de Nemours supplies high-purity resins and elastomers for drug delivery and surgical instruments, leveraging decades of materials science. Celanese focuses on engineering thermoplastics like medical-grade acetals for precision components in diagnostics.
Huntsman Corporation offers advanced polyurethanes and epoxy systems for adhesives in minimally invasive devices. Eastman Chemical provides sustainable cellulose-based materials for biodegradable implants and packaging. Johnson & Johnson integrates engineered materials into orthopedics and vision care, with MedTech innovations in joint implants. These companies navigate regulatory standards like ISO 13485, expanding portfolios amid rising demand for personalized medicine and minimally invasive therapies. Their global footprints, from Europe's chemical hubs to U.S. innovation centers, ensure supply chain resilience and rapid prototyping for healthcare advancements.
The medical engineered materials market features major players specializing in advanced polymers, plastics, foams, and adhesives for devices like implants, diagnostics, and surgical tools. Leading companies include B. Braun Melsungen AG (headquartered in Melsungen, Germany), BASF SE (Ludwigshafen, Germany), Celanese Corporation (Irving, Texas, USA), Covestro AG (Leverkusen, Germany), DSM (Heerlen, Netherlands), DuPont de Nemours Inc. (Wilmington, Delaware, USA), Eastman Chemical Company (Kingsport, Tennessee, USA), Evonik Industries AG (Essen, Germany), Huntsman Corporation (The Woodlands, Texas, USA), and Johnson & Johnson (New Brunswick, New Jersey, USA). These firms drive innovation through biocompatible materials, sustainability-focused polymers, and high-performance composites, supporting a market projected to grow from USD 23.9 billion in 2024 to USD 82.9 billion by 2033 at a 14.8% CAGR. B. Braun excels in infusion therapy components using engineered plastics, while BASF provides specialty chemicals for medical coatings and foams.
Evonik Industries AG leads with specialty polymers for implants and additive manufacturing, emphasizing biocompatibility and circular economy practices via collaborations with OEMs. Covestro AG develops polyurethane-based medical foams and films for wound care and flexible devices, bolstered by its chemical expertise. DSM, now Royal DSM N.V., pioneers bio-based polymers for orthopedics and cardiovascular applications, prioritizing patient-specific durability. DuPont de Nemours supplies high-purity resins and elastomers for drug delivery and surgical instruments, leveraging decades of materials science. Celanese focuses on engineering thermoplastics like medical-grade acetals for precision components in diagnostics.
Huntsman Corporation offers advanced polyurethanes and epoxy systems for adhesives in minimally invasive devices. Eastman Chemical provides sustainable cellulose-based materials for biodegradable implants and packaging. Johnson & Johnson integrates engineered materials into orthopedics and vision care, with MedTech innovations in joint implants. These companies navigate regulatory standards like ISO 13485, expanding portfolios amid rising demand for personalized medicine and minimally invasive therapies. Their global footprints, from Europe's chemical hubs to U.S. innovation centers, ensure supply chain resilience and rapid prototyping for healthcare advancements.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

